US Patent 11965040 Modulation of complement activity

Is a

Patent

Patent attributes

Patent Applicant

Ra Pharmaceuticals

Current Assignee

Ra Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119650400

Patent Inventor Names

Kelley Cronin Larson0

Nathan Ezekiel Nims0

Ping Ye0

Daniel Elbaum0

Kristopher Josephson0

Zhong Ma0

Michelle Denise Hoarty0

Hong Zheng0

...

Date of Patent

April 23, 2024

Patent Application Number

172362470

Date Filed

April 21, 2021

Patent Citations

‌

US Patent 8329169 Methods and compositions for the prevention and treatment of sepsis

‌

US Patent 6844010 Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix

‌

US Patent 6962781 In vitro evolution of nucleic acids and encoded polypeptide

‌

US Patent 7348401 Peptides that inhibit complement activation

‌

US Patent 7744910 Compounds and compositions for delivering active agents

‌

US Patent 8101586 Methods and compositions for the treatment of sterile inflammation

‌

US Patent 8377437 C3b antibodies and methods for the prevention and treatment of complement-associated disorders

‌

US Patent 8652477 Methods for treating disseminated intravascular coagulation by inhibiting MASP-2 dependent complement activation

...

Patent Primary Examiner

CPC Code

Patent abstract

The present invention provides modulators of complement activity. Also provided are methods of utilizing such modulators as therapeutics.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11965040 Modulation of complement activity

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11965040 Modulation of complement activity